Antibody Drug Conjugates Keep Growing: What You Need to Know
JD Supra: Mergers
DECEMBER 12, 2024
Over the past few years economic headwinds have resulted in fewer deals, with companies and private equity firms alike reassessing where to spend money. Since 2018, licensing deals totaling over US$60 billion have been signed regarding ADCs, with 2023 alone having at least 18 deals. What Are ADCs and Why Are They Growing?
Let's personalize your content